Rare Disease Day – The Fight Against Rare Diseases

mildred Uncategorised Leave a Comment

First launched by EURORDIS and its Council of National Alliances in 2008, Rare Disease Day is now in its 9th year and is recognized in over 80 countries on the last day of February each year. The main objective of Rare Disease Day is to raise awareness amongst the general public and decision-makers about rare diseases and their impact on …

Left: Founder Dr Jane Cardosa
Center: Dr Uwe Schlokat
Right: Michelle Gan

Interview with Dr Uwe Schlokat, CEO of Sentinext Therapeutics

Emily Event News Leave a Comment

Founded in 2008, Sentinext is a Malaysian biotech company which focuses on building innovative vaccines to protect Asia populations against infectious viral diseases. Using its proprietary Virus-like particle (VLP technology), Sentinext’s trademark project is to build vaccines for Hand foot mouth disease (HFMD), a highly prevalence infection among children in Asia. We have had the opportunity to interact with its CEO …

Capture 2

Maximizing injectables production: Enabling consistent supply

mildred Uncategorised Leave a Comment

One of the most significant trends today in our industry is the enormous growth of the injectable market. Injectables are becoming the single largest driver of the pharma/biotech market and offer tremendous opportunity. However, bringing an injectable to market is no small feat. Staying competitive, once in the market, can be just as challenging. Market and regulatory requirements regarding safety …

Capture 1

Meeting the inherent challenges of complex drug substances

mildred Uncategorised Leave a Comment

Realizing the full potential of a novel injectable drug compound is no small task. In the months and years that lead from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can slow development to a halt, often at key stages. A careful, systematic approach to identifying where and why these roadblocks …